ReviewFrontiers in immunology2026
Cerebrospinal fluid outflow pathways in neurodegeneration: nasopharyngeal lymphatics and the ocular glymphatic-like axis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The glymphatic system supports cerebrospinal fluid (CSF)-interstitial fluid (ISF) exchange and has been implicated, to different extents, in the transport or clearance of amyloid-β (Aβ), tau, lactate and other solutes. Although most studies have focused on CSF influx, astrocytic aquaporin 4 (AQP4) expression, perivascular localisation and polarisation, AQP4-mediated transmembrane water transport, and perivascular exchange, brain clearance also depends on efficient extracranial drainage of waste-containing fluid. In this narrative Review, we examine this 'outflow end', including meningeal lymphatic vessels, the cribriform plate-olfactory-nasal mucosal route, cranial perineural spaces, the nasopharyngeal lymphatic plexus, cervical lymphatic vessels and deep cervical lymph nodes. We highlight the skull base and nasopharyngeal lymphatic plexus as potential interfaces between intracranial CSF and extracranial lymphatic drainage and evaluate the route- and cargo-specific evidence for bulk-fluid and generic-tracer transport, soluble-protein clearance, aggregated-protein handling and immune-antigen drainage. We also consider experimental strategies targeting lymphatic contractility, VEGF-C-VEGFR3 signalling, mechanical stimulation, pressure gradients, AQP4-mediated transmembrane water transport and experimentally observed light-induced pupillary modulation. Throughout, we emphasise that evidence for individual cargoes, including Aβ, tau and α-synuclein, is uneven across anatomical routes and remains predominantly preclinical or indirect. Future studies integrating high-resolution lymphatic imaging, functional biomarkers and longitudinal or interventional designs are needed to determine whether altered CSF outflow is a consequence of neurodegeneration, a contributor to disease progression or a potentially modifiable process in neurodegenerative disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.